Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lenders

Showing results (221-230 of 253) with videos related to

Pageof 26
Sort By:
Blood Pressure|February 15, 2021
Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatmentMagdalena Januszewicz, Piotr Dobrowolski, Andrzej Januszewicz, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Gene expression profiling of benign and malignant pheochromocytomaFrederieke M Brouwers, Abdel G Elkahloun, Peter J Munson, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
The American Journal of Clinical Nutrition|April 11, 2014
The need to advance nutrition education in the training of health care professionals and recommended research to evaluate implementation and effectivenessPenny M Kris-Etherton, Sharon R Akabas, Connie W Bales, et al.
Journal of the American College of Cardiology|October 6, 2022
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art ReviewAndrzej Januszewicz, Paolo Mulatero, Piotr Dobrowolski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2023
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapyNikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2013
Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paragangliomaJyotsna U Rao, Udo F H Engelke, Richard J T Rodenburg, et al.
Journal of Hypertension|March 25, 2020
Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatmentMaria Gosk-Przybyłek, Adrian Doroszko, Piotr Dobrowolski, et al.
Pageof 26

Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
Blood Pressure|February 15, 2021
Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatmentMagdalena Januszewicz, Piotr Dobrowolski, Andrzej Januszewicz, et al.
Annals of the New York Academy of Sciences|November 15, 2006
Gene expression profiling of benign and malignant pheochromocytomaFrederieke M Brouwers, Abdel G Elkahloun, Peter J Munson, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Clinical Chemistry|August 12, 2018
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated <i>O</i>-Methylated Catecholamine MetabolitesGraeme Eisenhofer, Aleksander Prejbisz, Mirko Peitzsch, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2021
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay InaccuracyGraeme Eisenhofer, Max Kurlbaum, Mirko Peitzsch, et al.
The American Journal of Clinical Nutrition|April 11, 2014
The need to advance nutrition education in the training of health care professionals and recommended research to evaluate implementation and effectivenessPenny M Kris-Etherton, Sharon R Akabas, Connie W Bales, et al.
Journal of the American College of Cardiology|October 6, 2022
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art ReviewAndrzej Januszewicz, Paolo Mulatero, Piotr Dobrowolski, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2023
Baseline metastatic growth rate is an independent prognostic marker in patients with advanced BRAF V600 mutated melanoma receiving targeted therapyNikolaus B Wagner, Max M Lenders, Kathrin Kühl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2013
Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paragangliomaJyotsna U Rao, Udo F H Engelke, Richard J T Rodenburg, et al.
Journal of Hypertension|March 25, 2020
Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatmentMaria Gosk-Przybyłek, Adrian Doroszko, Piotr Dobrowolski, et al.
Pageof 26